Identification of Medicinal Products (IDMP) Standards Part 3: Steps to Prepare for IDMP Implementation

Posted 26 April 2017 By Dieter Schlaps

placeholder+image This article discusses the gap analysis and preliminary activities necessary to prepare a pharmaceutical company for the upcoming IDMP standards; it is the final article in a three part series on the standards and their respective implementation guidelines. The first two articles presented reasons for the new standard, the driving forces behind IDMP, and the concepts behind the standard as well as the current timelines for introducing IDMP in worldwide markets.

Share this article:

Categories: Drugs, Features, FDA, EMA, ISO

Tags:

Regulatory Exchange: Latest Updates From the Community